Abstract. Myosin is identified and purified from three different established Drosophila melanogaster cell lines (Schneider's lines 2 and 3 and Kc). Purification entails lysis in a low salt, sucrose buffer that contains ATP, chromatography on DEAE-cellulose, precipitation with actin in the absence of ATP, gel filtration in a discontinuous KI-KCI buffer system, and hydroxylapatite chromatography. Yield of pure cytoplasmic myosin is 5-10%.
lines (Schneider's lines 2 and 3 and Kc). Purification entails lysis in a low salt, sucrose buffer that contains ATP, chromatography on DEAE-cellulose, precipitation with actin in the absence of ATP, gel filtration in a discontinuous KI-KCI buffer system, and hydroxylapatite chromatography. Yield of pure cytoplasmic myosin is 5-10%.
This protein is identified as myosin by its crossreactivity with two monoclonal antibodies against human platelet myosin, the molecular weight of its heavy chain, its two light chains, its behavior on gel filtration, its ATP-dependent affinity for actin, its characteristic ATPase activity, its molecular morphology as demonstrated by platinum shadowing, and its ability to form bipolar filaments.
The molecular weight of the cytoplasmic myosin's light chains and peptide mapping and immunochemical analysis of its heavy chains demonstrate that this myosin, purified from Drosophila cell lines, is distinct from Drosophila muscle myosin. Two-dimensional thin layer maps of complete proteolytic digests of iodinated muscle and cytoplasmic myosin heavy chains demonstrate that, while the two myosins have some tryptic and alpha-chymotryptic peptides in common, most peptides migrate with unique mobility. One-dimensional peptide maps of SDS PAGE purified myosin heavy chain confirm these structural data. Polyclonal antiserum raised and reacted against Drosophila myosin isolated from cell lines cross-reacts only weakly with Drosophila muscle myosin isolated from the thoraces of adult Drosophila. Polyclonal antiserum raised against Drosophila muscle myosin behaves in a reciprocal fashion. Taken together our data suggest that the myosin purified from Drosophila cell lines is a bona fide cytoplasmic myosin and is very likely the product of a different myosin gene than the muscle myosin heavy chain gene that has been previously identified and characterized. M YOSIN, a hexameric protein that usually consists of two heavy and four light polypeptide chains, is the mechanochemical force transducer that interacts with actin to convert energy from the hydrolysis of ATP into force for muscular contraction (reviewed in Harrington and Rodgers, 1984) . In higher eukaryotes, cytoplasmic isoforms of myosin can be identified and presumably generate such diverse cellular motilities as platelet-mediated clot retraction, intracellular vesicle movement, cytoplasmic streaming, cell locomotion, and cytokinesis (Pollard, 1981) . Indeed, a functional role for cytoplasmic myosin in cytokinesis has been demonstrated best in antibody injection studies: anti-cytoplasmic myosin specifically inhibits actin-activated myosin ATPase activity in vitro and, when microinjected into living cells, inhibits the function of the contractile ring during cleavage in a specific and dose-dependent fashion (Mabuchi and Okuno, 1977; Kiehart et al., 1982) .
In avian and mammalian species, distinct isoforms of both myosin heavy and light chains are responsible for contractility in skeletal, cardiac, smooth muscle, and nonmuscle tissues (reviewed in Nadal-Ginard et al., 1982; Whalen et al., 1982; and Buckingham and Minty, 1983) . Further diversity is common even within a particular tissue: fast and slow isoforms of skeletal muscle, distinct isoforms of atrial and ventricular cardiac muscle (reviewed in Nadal-Ginard et al., 1982; Whalen et al., 1982; and Buckingham and Minty, 1983) , and distinct isoforms of cytoplasmic myosin (Burridge and Bray, 1975; Wong et al., 1985) have been identified. While the origin of this diversity is not uniformly clear, some of it is specified at the DNA level (Nadal-Ginard et al., 1982; Buckingham and Minty, 1983; Robbins et al., 1986) . In avian and mammalian species, the myosin heavy chain gene family apparently consists of ~10 distinct but closely related members. In avian species there are as many as 20 more distantly related forms. The heterogeneity in myosin heavy chain genes may reflect differences in sequence that alter regulation of the gene's expression, allowing coordinate expression with different sets of genes in different tissues or cell types at various times during development. Alternately, genes that differ in the sequence of their protein coding regions may result in appropriate expression of specific isoforms that are custom-tailored for their particular mechanochemical application.
In contrast to the mammalian and avian systems described above, only a single myosin heavy chain gene has been identified in Drosophila (Bernstein et al., 1983; Rozek and Davidson, 1983) . This suggests three interesting possibilities: That no diversity in myosin isoforms is necessary in Drosophila, that necessary diversity can be accommodated by posttranscriptional or posttranslational modifications of the products of a single myosin gene, or that additional, more distantly related, and therefore non-cross-hybridizing myosin heavy chain genes exist. Indeed, alternate splicing of the primary transcripts of both myosin heavy and light chain genes suggest that posttranscriptional modifications are responsible for at least some, albeit minor diversity in myosin heavy and light chain isoforms at the polypeptide level (Bernstein et al., 1986; Rozek and Davidson, 1986; Falkenthai et al., 1985) .
Here we purify a protein from Drosophila cell lines, identify it as myosin by five structural and three functional criteria, and establish on the polypeptide level that its heavy chains are extensively different from muscle myosin heavy chain isoforms. The substantial differences between muscle and cytoplasmic isoforms of Drosophila myosin heavy chain support the existence of a distinct myosin gene responsible for encoding this cytoplasmic polypeptide.
Preliminary accounts of this work were presented at meetings of the American Society for Cell Biology and the Biophysical Society Feghali, 1985, 1986) .
Materials and Methods

Cell Culture, Harvest, and Homogenization
Drosophila Kc and Schneider's 2 and 3 cells are distinct, established cell lines that are derived from embryonic tissue explants and do not display characteristics of myogenic cell lines (Schneider and Blumenthal, 1978) . They were grown by standard methods in spinner culture (Schneider and Blumenthal, 1978) . Approximately 15-30 g (wet weight) of cells grown to a density of 0.5-2 x 107 cells/ml were harvested by centrifugation and washed three times by gentle sedimentation and resuspension in ice-cold phosphate-buffered saline (PBS; 150 mM NaCI, 10 mM NaPO4, pH 7.2). All subsequent steps were performed at 0-4°C unless otherwise specified. Washed cells were resuspended in 10 vol of PBS, incubated in diisopropylfluorophosphate (5.7 mM final concentration) for 5 rain, washed in fresh PBS, then resuspended in 4-6 vol of ice-cold homogenization buffer (0.34 M sucrose, 20 mM imidazole-C1, pH 7.0, 5 mM EGTA, 5 mM ATE 5 mM dithiothreitol [DTT] , ~ 5 mM phenylmethylsulfonyl fluoride, 3 mM NAN,, 22 ~tM Pepstatin A, 0.25 mg/ml soybean trypsin inhibitor). Cells were lysed by sonication with a Branson sonifier set at maximum for a microtip (40 W). Cell homogenates were fractionated by centrifugation at 43,0(10 rpm in a Sorvall T647.5 rotor (137,600 g~v).
Purification of Myosin from the High Speed Supernatant
The supernatant was chromatographed on DEAE-cellulose (DE-52, Whatman Inc., Clifton, NJ; prepared as described by Pollard, 1982 ) that was equilibrated with homogenization buffer in the absence of proteolytic inhibitors. Approximately 100 ml of high speed supernatant was applied to a 2.5 × 35-cm column. The column was washed with 3-5 vol of homogenization buffer, then eluted with 0.8-1 liter of a linear, 0-0.5 M KCI gradient in homogenization buffer. Fractions that contained myosin were pooled.
Subsequent purification relied on the high affinity of myosin for actin in the absence of ATP. Endogenous Drosophila actin in the high speed supernatant or in selected fractions from DEAE-chromatography was polymerized by warming the sample to 25°C, adjusting the KCI concentration to 50-110 mM (fractions from DEAE were already ",,110 mM in KCI), then adding MgCI2 to a final concentration of 2 raM. To maximize recovery of myosin in subsequent steps, additional actin was required. Chicken F-actin 1. Abbreviation used in this paper: DTT, dithiothreitol. (in 50 mM KCI, 2 ram MgC12, 2 mM Tris-Cl, pH 8.0, 0.75 mM NAN3, 0.5 mM DTT, 0.2 mM ATP, 0.2 mM CaC12), purified by established protocols (Spudich and Watt, 1971; Pardee and Spudich, 1982) , was added to a final concentration of 0.25 mg/ml. Exogenous chicken actin did not contain any contaminating polypeptides that co-migrate with the 205-kD band as shown by SDS PAGE of heavily overloaded samples (data not shown). In addition, polyclonal antibodies made against the purified Drosophila cytoplasmic myosin (see below) did not cross-react with purified chicken skeletal muscle myosin on Western blots (data not shown). ATP was removed from the mixture of pooled DEAE fractions and exogenous actin after adding glucose (50 mM) and hexokinase (1 U/ml). After incubation for 30 rain at 25°C and then for 8-12 h at 0°C, the preparation was layered over a 30% sucrose cushion containing 50 mM KCI, 2 mM MgCI2, and I(3 mM imidazole-Cl, pH Z0, and filamentous actin. Any actin binding proteins were precipitated by centrifugation at 30,0(0)O3,000 rpm in a Sorvall T1270 rotor (61,300-126,000 g~) for 3 h. Without exogenous actin, more than half of the 205-kD polypeptide remained in the supernatant (even when the high speed supernatant of cell homogenate was not subjected to DEAE chromatography first; Fig. 1 B) . With added chicken actin, nearly all of the 205-kD polypeptide that otherwise remained in the supernatant was sedimented (Fig. 1 C) .
The actomyosin pellet was dissolved in 4.3 ml of KI buffer (0.72 M KI, 20 mM imidazole-Cl, pH 7.0, 1 mM EGTA, 5 mM DI'T, 5 mM ATP, 3 mM NAN3, 10% glycerol), homogenized with a tight-fitting glass pestle Doance, then clarified by centrifugation for 30 min at 30,000 rpm in a Sorvall T1270 (63,400 g~v). The clarified supernatant was gel filtered on a Al5-m (BioRad Laboratories, Richmond, CA) column (1.5 x 85 cm) equilibrated with KC1 buffer (0.6 M KCI, 10 mM imidazole-Cl, pH 7.0, 1 mM DTT, 1 mM EGTA, 3 mM NAN3, 10% glycerol) that was loaded with 12-19 ml of KI buffer just before addition of the protein sample.
Further purification of myosin was achieved by repetition of the actin affinity and gel filtration steps and/or by chromatography on hydroxylapatite (Bio-Rad Laboratories) equilibrated with 0.5 M KCI, 50 mM imidazole-Cl, pH 7.0, 1 mM EGTA, 0.5 mM DTT, 3 mM NAN3, 10% glycerol. Pooled fractions from gel filtration were added to the hydroxylapatite in batch (12-20 ml/ml bed) and tumbled slowly for '~12 h. The hydroxylapatite with absorbed protein was poured into a small column and washed with 5-10 vol of equilibration buffer. Absorbed proteins were eluted with a linear 0-300 mM KPO4 gradient in equilibration buffer.
Drosophila Thoracic Muscle Myosin
Myofibrils from Drosophila thoraces were isolated as detailed by Mogami et al. (1982) , then dissolved in K/buffer (see above). Subsequent purification of Drosophila muscle myosin was by gel filtration on an agarose A11-m column and by hydroxylapatite chromatography as described for the myosin purified from Drosophila cell lines.
SDS PAGE
PAGE was performed using standard methods (Laemmli, 1971) . To prepare samples that contained low concentrations of protein for SDS PAGE, aliquots were mixed with exogenous tRNA (from E. coli; Boehringer Mannheim Biocbemicals, Indianapolis, IN), precipitated with 10% TCA as described by Cabib and Polacheck (1984) , then resuspended in SDS sample buffer (Laemmli, 1971) with bromophenol blue as an indicator dye. The pH was adjusted to near neutrality by the vapor phase addition of NH4OH until the indicator turned blue. Polyacrylamide gels were stained with Coomassie Brilliant Blue as described elsewhere (Fairbanks et al., 1971) .
Western Blotting
Polypeptides were electmphoretically blotted from 5 % polyacrylamide gels by a modification of the procedure devised by Towbin etal. (1979; Kiehart et al. 1984a; ). Nitrocellulose blots were incubated briefly in STTMB (1f0 mM NaCl, 10 mM Tris-Cl, pH 7.7, 0.1% Triton X-100, 0.1% bovine serum albumin, 0.01% thimerosal) or Blotto (110 mM NaC1, 10 mM NaPO4, pH 7.4, 5% non-fat dry milk, 0.05% antifoam A, and 0.01% thimerosal; Johnson and Elder, 1983) , then overlaid with antibody in the same blocking buffer. Localization of antibody that bound to the blots was accomplished with t2~l-labeled second antibody (Kiehart et al., 1984a) or with peroxidase-labeled second antibody (HyClone Laboratories, Hogan, UT) diluted in STTMB or Blotto by 500-2,000-fold, followed by autoradiography or development for peroxidase reaction product with 4-chloro-1-napthol and hydrogen peroxide as substrates (Hawkes et al., 1982) .
Concentration of Myosin in Drosophila Cells in Culture
The concentration of myosin in Drosophila Schneider's 3 cells was estimated with an antibody binding assay similar to the one used by Kiehart and Pollard (1984) to estimate the concentration of myosin-II in Acanthamoeba extracts. Dilutions of hydroxytapatite-purified Drosophila cell myosin were used as standards, a 1,000-fold dilution of anti-Drosophila cytoplasmic myosin was used to probe a blot that contained both standards and whole cell samples, and peroxidase-labeled second antibody was used to estimate first antibody binding.
Analytical Gel Filtration
The Stokes radius of Drosophila cytoplasmic myosin was calculated from partition coefficients obtained by gel filtration of 0.5-mi samples containing 80 Ixg/mi myosin on a 1.5 × 85-cm agarose Al5-m column equilibrated with KCI buffer by the method of Ackers (1967) as described by Pollard et al. (1978) .
Two-dimensional Peptide Maps
Purified myosins were resolved on SDS PAGE, heavy chains were excised from the gel, iodinated, cleaved by trypsin (13 lxg/ml) or alpha-chymotrypsin (200 gg/mi) at 37°C for 8-12 h, then mapped on cellulose thin layer plates as detailed by Elder et al. (1977) . In each experiment, duplicate gel slices for each myosin were processed and revealed precise reproducibility. Tryptic maps were performed on three different preparations of cytoplasmic myosin and on two preparations of muscle myosin. Alpha-chymotryptic maps were performed on two samples each of Drosophila cytoplasmic and muscle myosin. In all cases, reproducibility between identically treated samples was excellent. To compare reliably the mobility of peptides from the two Drosophila myosin heavy chain isoforms, two plates were each spotted with peptides from either the cytoplasmic or the muscle isoforms, and a third composite plate was spotted with equal amounts of both. The presence of weak spots was verified by inspection of longer autoradiographic exposures and the resolution of closely spaced, strong spots was evaluated on shorter exposures. All 47 of the prominent cytoplasmic peptides and all 43 of the prominent muscle peptides were identified on the composite map. Thus the cytoplasmic and muscle isoform peptides could be compared directly, with confidence, despite subtle differences in peptide migration from one thin-layer plate to the next. To more quantitatively analyze the data each peptide on the cytoplasmic and the muscle myosin map was assigned a number and was located on the combined map. Peptides that overlapped were considered identical. This is clearly a simplification that tends to overestimate the degree to which the myosins are homologous.
Platinum Shadowing
Samples of Drosophila myosins in KCI column buffer were mixed with glycerol to a final concentration of 70% or were dialyzed into a mixture of 70% glycerol and 30% 0.6 M ammonium formate, pH 7.5 and rotary shadowed with platinum as described previously (Kiehart et al., 1984b; Tyler and Branton, 1980) . Electron micrographs were taken on a Philips 301 at magnifications of 25,000.
ATPase Activity
ATP hydrolysis by K+-EDTA -, Ca ++-, Mg ++-, and actin-activated Mg ++-ATPases were measured by 32p-gamma-ATP as described previously (Kiehart and Pollard, 1984) .
Actin-Myosin Binding Assay
Actin (5.3 gM in 2 mM Tris-C1, pH 8.0, 0.75 mM NaNa, 0.5 mM DTT, 0.2 mM ATE 0.2 mM CaCI:) was polymerized by the addition of salts (0.6 M KC1, 20 mM imidazole-Cl, pH 7.0, 4 mM MgC12, 3 mM NAN3, 0.1 mM DTT) and incubation at 37°C for 30 min. Parallel samples containing actin alone were treated identically. All concentrations shown are for the final concentration in the assay. Phalloidin (10 ttM) and glucose (50 mM) were added, then samples were either supplemented with 2 mM ATP or depleted of ATP by the addition of hexokinase (12 U/ml) and incubated for 5 min at 37°C. Each preparation was chilled to 0*C, mixed with myosin (42 nM, assuming a molecular mass of 480 kD), allowed to incubate for 10 min at 0°C, then layered onto a sucrose cushion (30% sucrose, 0.6 M KCI, 20 mM imidazole-C1, 4 mM MgC12, 3 mM NaNa, 0.1 mM DTT) with or without 2 mM ATP and sedimented for 40 min at 24 psi in a Beckman alrfuge (Beckman Instnmaents, Inc., Palo Alto, CA). The polypeptide composition of the supernatants and pellets was analyzed by SDS PAGE.
Polyclonal Antibodies against Drosophila Myosins
Polyclonal antibodies were prepared in rabbits by popliteal lymph node injection (Sigel et al., 1983) of 3-10 ttg of purified Drosophila cytoplasmic or muscle myosin in 0.2 ml of 400 mM NaCI, 5 mM imidazole-Cl, pH 7.0 mixed with an equal volume of Freund's complete adjuvant. After 1 mo rabbits were boosted with 10-20 gg of purified protein in the same solution mixed with Freund's incomplete adjuvant by injection into several sites intradermally. The antiserum raised against Drosophila cytoplasmic myosin reacts with a single, 205-kD polypeptide on immunoblots of both whole Schneider's 3 cell homogenates and of purified myosin from Drosophila cell lines (see Results). Preimmune serum showed no reaction against either fraction.
Other Proteins
Two monoclonal antibodies (PM 1 and PM 4) against human platelet myosin were prepared in collaboration with Drs. Albert Wong and Thomas D. Pollard. They react specifically with myosin from a variety of sources (manuscript in preparation; and Wong et al., 1985) . Chicken myosin and actin were purified from chicken muscle and muscle acetone powder by standard methods (Kielly and Harrington, 1960; Spudich and Watt, 1971; Pardee and Spudich, 1982) .
Protein Concentration
Protein concentration was estimated with an Amido black dye binding assay as described by Nakamura and co-workers (1985) , with chicken skeletal muscle myosin as a standard.
Reagents
All salts and pH buffers were reagem grade and deionized water (Millipore Corp., Bedford, MA) was used throughout these experiments. Suppliers of chromatographic resins are given in the text. ATE diisopropylfluorophosphate, EGTA, hexokinase, phenylmethylsulfonyl fluoride, pepstatin A, and soybean trypsin inhibitor were from Sigma Chemical Co., St. Louis, MO, and fliT was from Sigma Chemical Co. or Boehringer Mannheim Biochemicals. SDS was from Bethesda Research Laboratories (Gaithersburg, MD) and other reagents for SDS PAGE were from Bio-Rad. Schneider's 2 and 3, was tentatively identified as myosin by establishing its cross-reactivity with two monoclonal antibodies directed against human cytoplasmic myosin heavy chain (Fig. 1) . SDS PAGE and Western blots overlaid with these antibodies were used to follow the distribution of the 205-kD polypeptide during cell fractionation and subsequent purification from Schneider's 3 cells. The majority of the 205-kD polypeptide was extracted into the high speed supernatant of cell homogenate as revealed by monoclonal anti-platelet myosin overlay of Western blots of pellet and supernatant fractions (Fig. 1) overlaid with PM-4, a monoclonal anti-human platelet myosin antibody. Antibody binding was localized with peroxidase-labeled second antibody. The amount of each fraction that was loaded is indicated in parentheses and is expressed in thousandths of a percent of the total protein (or volume) present in the fraction. Comparison of the relative intensity of peroxidase label at 205 kD in the supernatant and pellet fractions in B and C reveal that most of the 205-kD polypeptide is not recovered in the actomyosin pellet unless exogenous actin is included. Chicken skeletal muscle myosin, also stained by this antibody, is in the lane labeled CM. Samples were obtained from four steps: (A) The homogenate, including the whole cell homogenate (Wh), the high speed supernatant of cell homogehate (S), and the high speed, cell debris pellet (P). (B) The endogenous actin pelleting steps (Endo. Actin; steps not usually included during standard purification but shown here to document the efficacy of adding exogenous actin), including the supernatant (S) that followed centrifugation of the endogenous actin-myosin complex and the actomyosin pellet (P). (C) The exogenous actin pelleting steps (Exog. Actin) including the supernatant (S) following centrifugation of the supernatant from B after the addition of exogenous chicken skeletal muscle actin and the exogenous actin-myosin complex pellet (P). (D) The KI-solubilized actomyosin pellet after centrifugation that resulted in a clarified supernatant (S) and the KI-insoluble pellet (P).
Results
Identification
havior of the 205-kD polypeptide during purification, in part, helps to identify the polypeptide as a bona fide myosin.
The high speed supernatant was chromatographed on DEAE cellulose to remove contaminating nucleic acids and enrich for the 205-1d) polypeptide. Fractions eluting between 0.13 and 0.2 M KC1 contained an immunoreactive 205-kD polypeptide and a prominent 205-ki) polypeptide on Coomassie Blue-stained gels. These fractions were pooled.
Like other myosins, more of the protein that contains 205-kD polypeptide binds to F-actin in the absence of ATP than in its presence as shown in co-sedimentation experiments (Fig. 2) . To take advantage of this property during purification of the Drosophila 205-kD polypeptide, exogenous F-actin (see Materials and Methods) was added to pooled fractions from DEAE, ATP was removed by addition of hexokinase and glucose, then the actin and actin-binding proteins were precipitated by high speed centrifugation through a 30 % sucrose cushion. Pellets were dissociated in potassium iodide solution and fractionated by gel filtration (Fig. 3) .
Hydroxylapatite chromatography of fractions pooled from the gel filtration column allowed further purification of myosin, which eluted as a peak at 210 mM KPO4 (Fig. 3 b) . SDS PAGE of peak fractions revealed at least two light chains migrating at 16 and 18 kD.
Typically 300-500 I~g of hydroxylapatite-purified myosin was obtained from 20-25 g (wet weight) of Drosophila Schneider's 3 cells. The concentration of myosin in whole cells was estimated by comparing antibody binding on Western blots of whole cells and of purified cellular myosin (Fig.  4) . The polyclonal, rabbit antibody that was used for these experiments was raised against purified myosin from Drosophila cells and is specific for myosin as demonstrated by antibody overlay of nitrocellulose blots of SDS PAGE resolved purified myosin or of whole cell sample (Fig. 4 ). Gel lanes that had an equivalent of 53 nl of whole cells contained ~10-15 ng of myosin. Thus, the concentration of myosin in these ceils is '~0.5 ~tM, and the yield of myosin in the most highly purified fractions is 5-10%. 
Partial Characterization of Myosin from Drosophila Cell Lines. The 205-kD polypeptide and the K+-EDTA
ATPase activity, a functional signature of myosin, coeluted precisely on gel filtration: specific activity was essentially constant across the peak (•550 nmol Pi/mg.min; Fig. 3 a) . Further analysis of the ATPase activities of the fractions that contained 205-kD polypeptide showed other activities indicative of myosin. They had comparable activities in 10 mM CaCl2, 0.5 M KC1, or 0.05 M KC1 and little activity in the presence of 5 mM MgC12 in 0.01 M KCI. Gel filtration revealed that the 205-kD polypeptide elutes with a partition coefficient (Kd) of 0.136, which corresponds to a Stokes radius of 17 rim.
Electron microscopy of rotary-shadowed specimens dried from glycerol (Fig. 5) revealed that the predominant molecular species in the fractions that contain 205-kD polypeptide and K+-EDTA ATPas¢ activity was myosin: The two-headed molecules have a long tail (132 nm average) and aggregate in 180 mM ammonium formate to form bipolar filaments that have a bare zone averaging 204 nm (:t: 19 rim, n = 5) with projecting heads at each end (14.9 + 3 heads per end). This suggests that each filament consists of 16 myosin molecules with antiparallel tails that overlap >60 nm or almost half of their length.
Drosophila Cytoplasmic and Muscle Myosin Isoforms Can Be Distinguished Structurally and ImmunochemicaUy
In addition to differences between the molecular weight of this myosin's and Drosophila muscle myosin's light chains, structural and immunological analyses of its heavy chains suggest that this myosin is a true cytoplasmic isoform of myosin, distinct from the muscle isoforms previously isolated from Drosophila thorax.
Two-dimensional Peptide Maps Reveal Significant Differences between Drosophila Cytoplasmic and Thoracic Muscle Myosin Heavy
Chains. The structural relationship between these two Drosophila myosins was revealed in two-dimensional peptide mapping experiments (Fig. 6) . Even cursory inspection of the maps revealed significant differences in the structure of these two related proteins: most of the cytoplasmic and muscle myosin peptides appeared to migrate with unique mobility as determined by comparing the position, shape, and intensity of the various spots (several uniquely migrating spots are highlighted with arrows in Fig. 6 ). When the maps were compared semiquantitatively (see grate with unique mobility on the two-dimensional maps. The remaining peptides overlapped on the composite map. Some of these overlapping peptides probably precisely comigrated with one another while others were close to one another but likely to be distinct. Thus, the resolution of the semi-quantitative analysis used was insufficient to document the relationship between these polypeptides unambiguously and tended to overestimate the degree to which the myosins are homologous.
Overall, the data suggest that, while the two types of myosin isolated from Drosophila share some homology, significant differences distinguish Drosophila cytoplasmic from muscle myosin. Two-dimensional maps of alpha-chymotryptic peptides of the two Drosophila myosin isoforms and onedimensional maps of peptides generated by V8 protease verify the significant differences in the primary sequences of the two polypeptides (data not shown).
Drosophila Cytoplasmic and Muscle Myosin Heavy Chains Can Be Distinguished lmmunoiogicaUy.
Polyclonal antisera raised against either purified Drosophila cytoplasmic myosin or purified Drosophila muscle myosin were used to overlay Western blots of Drosophila cytoplasmic and muscle myosins (Fig. 7) . These experiments show that the two myosin heavy chain isoforms are significantly different immunologically.
Anti-cytoplasmic myosin antibodies distinguished easily between the cytoplasmic and muscle isoforms of Drosophila myosin heavy chain (Fig. 7) . At a 200-fold dilution of anticytoplasmic myosin, 1 ng of the cytoplasmic myosin isoform was detectable. 100 ng of the muscle myosin isoform was required to produce a peroxidase reaction product of only slightly greater intensity. At a 2,000-fold dilution of anticytoplasmic myosin antiserum, reaction products with 10 ng of cytoplasmic myosin and 1,000 ng of muscle myosin were comparable. Thus the anti-cytoplasmic myosin bound selectively to cytoplasmic myosin by approximately two orders of magnitude. The immunological differences between the cytoplasmic and muscle isoforms of Drosophila myosin were more striking when the Western blots were probed with the anti-muscle myosin antiserum. While as little as 1 ng of muscle myosin was detected by 200-fold dilutions of the anti-muscle antiserum, 1,000 ng of cytoplasmic antigen was necessary to produce a detectable reaction product. At anti-muscle myosin dilutions of 2,000-fold the reaction product with 1 ng of muscle myosin appeared approximately equivalent to the reaction product observed with 1,000 ng of cytoplasmic myosin. Thus the anti-muscle antiserum was even more selective than the anti-cytoplasmic antiserum. The immunological differences between these isoforms of Drosophila myosin have recently been confirmed with antisera from two mice immunized with Drosophila muscle myosin and two mice immunize.d with Drosophila cytoplasmic myosin. Like the rabbit polyclonal antisera described above, each of the four antisera displays marked specificity for the isoform against which it was made (Lutz, D. A., and D. P. Kiehart, unpublished observations).
Discussion
Five structural criteria, i.e., cross-reaction with monoclonal antibodies directed against human platelet myosin, molecular weight of myosin heavy chains, existence of two heterologous light chains, behavior on gel filtration, molecular architecture as revealed by electron microscopy of platinumshadowed specimens, and three functional criteria, i.e., ATP-dependent association with actin, high K+-EDTA, and Ca++-ATPase activities, and ability to form bipolar filaments, demonstrate that this protein, purified from Drosophila cells in culture, is a bona fide myosin.
Electron microscopy of platinum-shadowed specimens and gel filtration of native cytoplasmic myosin demonstrate that this myosin is similar in size and shape to other myosins and as a consequence likely consists of two heavy chains and four light chains. By SDS PAGE, the molecular mass of the Drosophila cytoplasmic myosin heavy chains is 205 kD. Two bands, migrating on SDS PAGE at 16 and 18 kD, co-purify with the 205-kD heavy chain and are likely myosin light chains. The molecular mass of the light chains of Drosophila muscle myosin are 34 or 31 kD (LC 1), 30 kD (LC 2), and 20 or 18 kD (LC 3), respectively (Takano-Ohmuro et al., 1983; Toffenetti, J., personal communication) . Thus at least one of these light chains is probably unique to the cytoplasmic myosin isoform. In preliminary experiments, actin activation of the Mg ++-ATPase activity of Drosophila cytoplasmic myosin has not been demonstrated. This is not surprising and is probably due to our failure to identify appropriate conditions for activity, which may require variation in solution conditions or in the state of phosphorylation of the heavy or light chains.
In addition to differences between the molecular weight of Drosophila cytoplasmic and muscle myosin light chain poly- peptides, two independent peptide mapping protocols and six independent polyclonal antisera establish that the cytoplasmic isoform of Drosophila myosin heavy chain is structurally and immunologically distinct from the isoform isolated from thoraces of adult flies. The two-dimensional peptide maps reveal some homology between cytoplasmic and muscle isoforms, but clearly demonstrate significant differences in the constituent peptides of the myosin heavy chains. One-dimensional peptide maps establish that the differences between the polypeptides revealed by the two-dimensional mapping protocol were not simply an artifact of differential iodination of tyrosine, cysteine, histidine, or tryptophan residues on the respective peptides.
Six polyclonal antisera, one rabbit, and two mouse sera directed against the cytoplasmic isoform, and one rabbit and two mouse sera directed against the muscle isoform, underscore the differences between these molecules. These findings suggest that the two Drosophila isoforms are as different as cytoplasmic and striated muscle isoforms of myosin isolated from vertebrate sources.
It is clear that differential splicing of myosin heavy and light chain genes gives rise to heterogeneity in the mature messenger RNAs that encode for various isoforms of Drosophila muscle myosin heavy and light chains (Bernstein et al., 1983; Rozek and Davidson, 1983; Bernstein et al., 1986; Falkenthal et al., 1985) . However, differential splicing results in significant changes in the sequence of the 3' untranslated region of both myosin heavy and light chain mRNAs and can account for only minor changes in the amino acid sequence near the carboxy-termini of these polypeptides. One muscle myosin heavy chain isoform has 27 unique carboxy-terminal amino acids, while the other isoform has a single, unique carboxy-terminal amino acid (Bernstein et al., 1986; Rozek and Davidson, 1986) . Differential splicing of the Drosophila alkali light chain primary transcript results in two isoforms that differ only in the sequence of the 14 amino acids at their carboxy-terminal ends (Fallkenthal et al., 1985) . Thus, no currently known differential splicing patterns could account for the extensive differences in the myosin polypeptide isoforms that we document through structural and immunological analyses of the purified proteins.
In concert, the observations provide good, albeit circumstantial evidence for the existence of at least one additional myosin heavy chain gene in Drosophila. Since our data suggest that the cytoplasmic and muscle isoforms are substantially different at the polypeptide level, it is not surprising that the existence of a second myosin heavy chain gene was missed when muscle myosin DNA probes were used to search for additional myosin genes in Drosophila (Bernstein et al., 1983; Rozek and Davidson, 1983) . Supporting this conclusion is the observation that, although hybridization between nematode muscle and Acanthamoeba myosin genes shows some detectable homology between muscle and cyto-plasmic myosin genes, in chickens and in humans the muscle myosin DNA probes have failed to identify unambiguously the gene(s) for cytoplasmic myosin (Leinwand, L., personal communication). Unequivocal demonstration of the existence of a second myosin heavy chain gene in Drosophila that encodes the cytoplasmic myosin isoform will require identification and cloning of the cytoplasmic gene and subsequently its detailed comparison with the gene for the muscle isoform that has already been identified and cloned.
The study of the myosin polypeptides and their genes in Drosophila may be particularly rewarding because, in contrast to the vertebrate systems, the apparently small number of myosin genes (perhaps as few as two) should allow a more complete description of the relationships between myosin genes, the regulation of their expression, and the functional importance of the diversity between the polypeptide isoforms that they encode. In addition, classical genetics and modern molecular biology, including mutant analysis, reverse genetics, production of anti-sense message, and germ and somatic cell line transformation can be brought to bear on the mechanism of myosin function and the role this protein plays in cellular homeostasis and movements during early embryogenesis.
